行情

ANIK

ANIK

阿尼卡医疗
NASDAQ

实时行情|Nasdaq Last Sale

45.43
-1.68
-3.57%
盘后: 45.43 0 0.00% 16:30 01/17 EST
开盘
47.44
昨收
47.11
最高
47.44
最低
45.26
成交量
11.45万
成交额
--
52周最高
75.72
52周最低
29.01
市值
6.48亿
市盈率(TTM)
20.99
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ANIK 新闻

  • 蛋壳公寓闯关IPO 上市后盈利痛点更受关注
  • 一财网.2小时前
  • 成功登陆美股!蛋壳公寓如何讲好“新租赁”故事
  • 东方财富网.2小时前
  • Lululemon:谜题待解
  • 界面.4小时前
  • 复飞之路再现波折 波音737Max软件又曝新缺陷
  • 中国新闻网.5小时前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

ANIK 简况

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
展开

Webull提供Anika Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。